Fetal therapy in fetal thyrotoxicosis: A case report

Fetal Diagnosis and Therapy

Volumn 23, Issue 2, 2008, Pages 114-116

  Srisupundit, Kasemsri ^a,b   Sirichotiyakul, Supatra ^a   Tongprasert, Fuanglada ^a   Luewan, Suchaya ^a   Tongsong, Theera ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Fetal therapy; Fetal thyrotoxicosis

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE SODIUM; PROPYLTHIOURACIL;

ADULT; ARTICLE; CASE REPORT; CORDOCENTESIS; FEMALE; FETAL THERAPY; FETUS; FETUS DISEASE; FETUS HEART RATE; FETUS OUTCOME; GESTATIONAL AGE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; PREGNANT WOMAN; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; TACHYCARDIA; THYROID FUNCTION TEST; THYROTOXICOSIS; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; ANTITHYROID AGENTS; FEMALE; FETAL DISEASES; FETAL THERAPIES; GRAVES DISEASE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; THYROTOXICOSIS;

EID: 40049093261     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111589     Document Type: Article

References (16)

1. Zimmerman D: Fetal and neonatal hyperthyroidism. Thyroid 1999;9:727-733.
2. Bruinse HW, Vermeulen-Meiners C, Wit JM: Fetal treatment for thyrotoxicosis in non-thyrotoxic pregnant women. Fetal Ther 1988;3:152-157.
3. Heckel S, Favre R, Schlienger JL, Soskin P: Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease: a case report. Fetal Diagn Ther 1997;12:54-58.
4. Yanai N, Shveiky D: Fetal hydrops, associated with maternal propylthiouracil exposure, reversed by intrauterine therapy. Ultrasound Obstet Gynecol 2004;23:198-201.
5. Duncombe GJ, Dickinson JE: Fetal thyrotoxicosis after maternal thyroidectomy. Aust NZ J Obstet Gynaecol 2001;41:224-227.
6. Volumenie JL, Polak M, Guibourdenche J, Oury JF, Vuillard E, Sibony O, et al: Management of fetal thyroid goitres: a report of 11 cases in a single perinatal unit. Prenat Diagn 2000;20:799-806.
7. Ting MK, Hsu BR, Huang YY, Lin JD, Chen TC: Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report. Changgeng Yi Xue Za Zhi 1999;22:492-497.
8. Bowman ML, Bergmann M, Smith JF: Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 1998;8:795-796.
9. Krude H, Biebermann H, Krohn HP, Dralle H, Gruters A: Congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 1997;105:6-11.
10. Wallace C, Couch R, Ginsberg J: Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid 1995;5:125-128.
11. Watson WJ, Fiegen MM: Fetal thyrotoxicosis associated with nonimmune hydrops. Am J Obstet Gynecol 1995;172:1039-1040.
12. Maternal-Fetal Medicine: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Faculty of medicine, Chiang Mai University, 2548. Annual Report, 2005.
13. Nachum Z, Rakover Y, Weiner E, Shalev E: Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 2003;189:159-165.
14. Peleg D, Cada S, Peleg A, Ben-Ami M: The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 2002;99:1040-1043.
15. Thorpe-Beeston JG: Fetal endocrinology; in Rodeck CH, Whittle MJ (eds): Fetal Medicine: Basic Science and Clinical Practice. London, Churchill-Livingstone, 1999, p 199.
16. Radaelli T, Cetin I, Zamperini P, Ferrazzi E, Pardi G: Intrauterine growth of normal thyroid. Gynecol Endocrinol 2002;16:427-430.